Medikinet MR modified-release capsules, hard
- Name:
Medikinet MR modified-release capsules, hard
- Company:
Flynn Pharma Ltd
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may be renewed (B)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 23/03/21
(Click to Download)Click on this link to Download PDF directly
Flynn Pharma Ltd
Company Products
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 23 March 2021 PIL
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
Update of the package leaflet to adapt potential side effects in line with the reference product Ritalin.
Updated on 13 November 2019 SPC
Reasons for updating
- Change to section 4.6 - Pregnancy and lactation
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 19 June 2017 PIL
Reasons for updating
- Change to section 4.8 - Undesirable effects
Free text change information supplied by the pharmaceutical company
Updated on 19 June 2017 SPC
Reasons for updating
- Change to section 4.8 - Undesirable effects
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Updated on 19 June 2017 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may be renewed (B)
Updated on 17 November 2016 PIL
Reasons for updating
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Free text change information supplied by the pharmaceutical company
Use with other medicines
Medikinet MR must not be taken together with H2 receptor blockers or antacids, as this could lead to a faster release of the total amount of active substance.
Updated on 17 November 2016 SPC
Reasons for updating
- Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
Legal category: Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
Use with other medicines
Medikinet MR must not be taken together with H2 receptor blockers or antacids, as this could lead to a faster release of the total amount of active substance.
Updated on 11 August 2016 PIL
Reasons for updating
- New SPC for medicines.ie
Free text change information supplied by the pharmaceutical company
Updated on 11 August 2016 SPC
Reasons for updating
- New SPC for medicines.ie
Legal category: Product subject to medical prescription which may be renewed (B)